Subgroup variation in the U.S. drinking patterns: Results of the 1992 National Longitudinal Alcohol Epidemiologic Study. J Subst Abuse 1995;7:331–4., , , .
Epidemiology of alcoholic liver disease. Semin Liver Dis 2004;24:217–32., .
Liver disease in alcohol and hepatitis C. Best Pract Res Clin Gastroenterol 2003;17:649–62., .
Treatment of alcoholic hepatitis. Clin Liver Dis 2005;9:103–34., .
Long-term prognosis of fatty liver: Risk of chronic liver disease and death. Gut 2004;53:750–5., , , , et al.
Social epidemiology of chronic liver disease and cirrhosis mortality in the United States 1935–1977: Trends and differentials by ethnicity, socioeconomic status and alcohol consumption. Hum Biol 2000;72:801–20., .
Drinking habits as cofactors of risk for alcohol induced liver damage. Gut 1997;41:845–50., , , , et al.
Alcohol and cirrhosis: dose-response or threshold effect?J Hepatol 2004;41:25–30., , , .
Lower risk for alcohol-induced cirrhosis in wine drinkers. Hepatology 2002;35:868–75., , , .
Liver disease in heavy drinkers with and without alcohol withdrawal syndrome. Alcohol Clin Exp Res 2004;28:131–36., , , , et al.
Drinking pattern and mortality in middle-aged men and women. Addiction 2004;99:323–30., , , , .
Risk factors for alcoholic liver disease in China. World J Gastroenterol 2004;10:2423–6., , , , , et al.
The role of hypoxia in the pathogenesis of alcoholic liver disease. Hepatol Res 2004;29:69–74..
An alcoholic binge causes massive degradation of hepatic mitochondrial DNA in mice. Gastroenterology 1999;117:181–90., , , , et al.
Increased susceptibility to liver disease in relation to alcohol consumption in women. Scand J Gastroenterol 1987;22:1251–6., , .
Prediction of risk of liver disease by alcohol intake, sex, and age: A prospective population study. Hepatology 1996;23: 1025–9., , , , et al.
Epidemiology of alcoholic liver disease. Prog Liv Dis 1976;5:494–515..
Pathogenesis of alcoholic liver disease: Newer mechanisms of injury. Keio J Med 1999;48:184–8..
Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancer 1997;349:825–32., , .
Clinical course and risk factors of hepatitis C virus related liver disease in the general population: Report from the Dionysos study. Gut 1999;44:874–80., , , , , et al.
Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis. Hepatology 1998;27:914–19., .
Impact of moderate alcohol consumption on histological activity and fibrosis in patients with chronic hepatitis C, and specific influence of steatosis: a prospective study. Aliment Pharmacol Ther 2003;17:1031–7., , , , , .
Risks of a range of alcohol intake on hepatitis C-related fibrosis. Hepatology 2004;39:826–34., , , , et al.
Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology 2001 Oct;34(4 Pt1):809–16., , , , et al.
Influence of alcohol on the progression of hepatitis C virus infection: A meta-analysis. Clin Gastroenterol Hepatol 2005;3(11): 1150–9., , .
Hepatitis C and hospital outcomes in patients admitted with alcohol-related problems. J Hepatol 2006;44: 262–6., , , , .
Relationship between hepatitis C virus subtypes and clinical features of liver disease seen in alcoholics. J Hepatol 1995;22:130–4., , , , , et al.
High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors. Hepatology 1999;29:1704–7., , , , , , et al.
The interaction of alcoholic liver disease and hepatitis C. Hepatogastroenterology 1998;45:331–9., .
The epidemiology and prevention of hepatocellular carcinoma. Semin Oncol 2001;28:441–9., .
Dietary and nutritional abnormalities in alcoholic liver disease: A comparison with chronic alcoholics without liver disease. Am J Gastroenterol 1997;92:777–83., , , , .
Nutritional aspects of alcoholic liver disease. Clin Liver Dis 2005;9:67–81., .
Overweight as a risk factor or a predictive sign of histological liver damage in alcoholics. Am J Clin Nutri 1988;47:235–8., , , .
Excess weight as a risk factor for alcoholic liver disease. Hepatology 1997;25:108–11., , , , , .
Risk factors for alcoholic liver disease in China. World J Gastroenterol 2004;10:2433–66., , , , , .
Dietary fat and alcoholic liver disease. Hepatology 1998;28:901–9..
Is alcoholic hepatitis an indicator for transplantation? Current management and outcomes. Liver Transplantation 2005;11(suppl 1): 21–4.,
Improvement of prognostic power of the Child-Pugh classification of liver cirrhosis by hyaluronan. J Hepatol 2003;39:947–53., , , , , .
Assessment of prognostic factors in alcoholic liver disease toward a global quantitative expression of severity. Hepatology 1983;3:896–905., , , .
Alcoholic hepatitis: Clinicopathologic features and therapy. Semin Liv Dis 1988;8:91–102..
Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone. Gastroenterology 1996;110:1847–53., , , , , et al.
Utility of the Mayo end-stage liver disease. MELD) score in assessing prognosis of patients with alcoholic hepatitis. BMC Gastroenterol 2002;2:1–5., , .
The diagnostic value of biomarkers. Ash test) for the prediction of alcoholic steato-hepatitis in patients with chronic alcoholic liver disease. J Hepatol 2006;44:1175–85., , , , et al.
Diseases of the liver. 6th edition. Philadelphia: JB Lippincott Co, 1987, pp. 669–685.. Alcoholic hepatitis. In: , editors.
Meld score is a better prognostic model than Child-Turcotte-Pugh score on discriminant function score in patients with alcoholic hepatitis. J Hepatol 2005;42:700–6., , , .
Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone. Hepatology 2003;38:1363–9., , , , , et al.
Natural history and evaluation of prednisolone therapy. Ann Intern Med 1971;74:311–21., , , .
Corticosteroid therapy in severe alcoholic hepatitis. N Engl J Med 1971;284:1350–5., , , , .
Prednisone therapy of acute alcoholic hepatitis. Ann Intern Med 1973;79:625–31., , , , , .
Adrenocorticosteroid therapy in alcoholic hepatitis: A prospective, double-blind randomized study. Am J Dig Dis 1977;22:477–84., , , , , .
Treatment of alcoholic hepatitis with encephalopathy. Comparison of prednisolone with caloric supplements. Gastroenterology 1978;74:169–73., , .
Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 1978;75:193–9., , , , , .
A controlled trial of 6-methylprednisolone in acute alcoholic hepatitis. Am J Gastroenterol 1978;69:443–9., , , , .
Double-blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy. Gastroenterology 1980;78:524–9., , , , .
Controlled trial of methylprednisolone therapy in severe acute alcoholic hepatitis. Gut 1982;23:75–9., , .
Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone. N Engl J Med 1984;311:1464–70., , , , et all.
Traitement de L'hépatite alcoolique aiguë par la prednisolone. Presse Med 1987;16:769–72., , , , .
Methylprednisolone therapy in patients with severe alcoholic hepatitis: A randomized multicenter trialAnn Intern Med 1989;11:685–90., , , , , , .
A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N Engl J Med 1992;326:507–12., , , , et al.
Place de la corticotherapyie dans le traitement des hépatite alcoolique aiguë. Resultats dune métaanalyse. Gastroenterol Clin Biol 1991;15:223–28., , , , , , .
Treatment of alcoholic hepatitis. Gastroenterol Int 1989;2:208–16., , .
Do corticosteroids reduce mortality from alcoholic hepatitis. Ann Intern Med 1990;113:299–307., .
Corticosteroids improve short term survival in patients with severe alcoholic hepatitis.AH): Individual data analysis of the last three randomized placebo controlled double-blind trials of corticosteroids in severe AH. J Hepat 2002;36:547–8., , , , et al.
Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone. Gastroenterology 1996;110:1847–55., , , , et al.
Alcoholic hepatitis superimposed on cirrhosis, clinical significance of long term prednisolone treatment. Scan J Gastroenterol 1976;22:305–12., , , , and .
Severe acute alcoholic hepatitis: an audit of medical treatment. Med J 2002;95:108–111., .
Alcoholic liver disease: Proposed recommendations for the American College of Gastroenterology. Am J Gastroenterol 1998;93:2022–36., .
Phosphodiesterase 4 inhibitors prevent cytokine secretion by T lymphocytes by inhibiting nuclear factor KB and nuclear factor of activated T cells activation. J Pharmacol Exp Ther 2001;299:753–59., , , , .
Pentoxifylline, a drug with rheological effects, decreases portal pressure in an experimental model of cirrhosis. Eur J Gastroenterol Hepatol 1997;9:27–31., , , , .
Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology 2000;119:1787–91., , , , , .
Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study. J Hepatol 2002;37:448–55., , , , et al.
Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis. J Hepatol 2003;38:518–20., , , , , , , et al.
A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis. Hepatology 2004;39:1488–90., , , , , , et al. .
Anti-tumor necrosis factor-alpha therapy in severe alcoholic hepatitis: are large randomized trials still possible?J Hepatol 2004;38:419–25., , , , .
Infliximab and alcoholic hepatitis. Hepatology 2004;40:499–500., , , .
Infliximab and prednisolone: Too much of a good thing?Hepatology 2004;39:1488–90., , .
A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis. Am J Gastroenterol 2004;99:255–60., , , , et al.
Long-term ethanol consumption alters the hepatic response to the regenerative effects of tumor necrosis factor alpha. Hepatology 1993;17:1066–73., , , , et al.
A randomized placebo controlled trial of vitamin E for alcoholic hepatitis. J Hepatol 2004:40:40–6., .
Effects of long-term vitamin supplementation in alcoholic cirrhotics. J Am Coll Nutri 1995;14:192–6., , , .
Alcohol-induced toxic hepatitis—a “ free radical ” associates disease. Lowering facility by adjuvant antioxidant therapy. Z Gesamte In Med 1993;48:490–6., , , .
S-adenosylmethionine in alcoholic liver cirrhosis: A randomized, placebo-controlled, double-blind, multicenter clinical trial. Hepatol 1999;30:1081–9., , , , , , et al.
S-Adenosyl-L-methionine for alcoholic liver diseases. Cochrane Database Syst Rev 2004:3, .
S-adenosyl-L-methionine in the treatment of alcoholic liver disease: introduction and summary of the symposium. Alcohol 2002;27:151–4., .
A pilot study to investigate the use of oxypentifylline (pentoxifylline) and thalidomide in portal hypertension secondary to alcoholic cirrhosis. Aliment Pharmacol Ther 2004;19:78–82., , , , .
Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2000;96:1723–32., , , , , , et al.
Probiotics and antibiotics to TNF inhibit inflammatory activity and improve non-alcoholic fatty liver disease. Hepatology 2003;37:347–50., , , , , et al.
Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis. J Hepatol 2001;34:330–3., , , , , .
Apoptosis in alcoholic hepatitis: A novel therapeutic target?J Hepatol 2001;34:248–53..
Managing severe alcoholic hepatitis complicated by renal failureQ J Med 1993;86:649–56., , , , , et al.
Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis. J Hepatol 2003;38:104–6., , , , , .
Veterans Administration Cooperative Study Group on Alcoholic Hepatitis. Am J Med 1984;76:211–22., , , , . .
Nutritional supplementation in chronic liver disease: an analytical review. Hepatology 1994;19:518–33., .
Liver cirrhosis: rationale and modalities for nutritional support—the European Society of Parenteral and Enteral Nutrition consensus and beyond. Curr Opin Clin Nutri Metab Care 1999;2:345–9., .
Protein-calorie malnutrition and the etiology of cirrhosis. Am J Gastroenterol 1997;92:734–8., .
Propylthiouracil for alcoholic liver disease. Cochrane Database Syst Rev 2005;(4):CD002800., , .
S-adenosyl-L-methionine for alcoholic liver diseases. Cochrane Review Cochrane Database Syst Rev 2001;4:CD002235., .
Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis. Cochrane Database Syst Rev 2005;(2):CD002148., .
Anabolic-androgenic steroids for alcoholic liver disease. CochraneDatabase Syst Rev 2003;(1):CD003045., , .
Alcohol and hepatitis C. Semin Liver Dis 2004;24:305–15., .
Orthotopic liver transplantation for alcoholic liver disease: a retrospective analysis of survival, recidivism, risk factors predisposing to recidivism. Liver Transplant 2001;7:418–27., , , et al.
Liver transplantation in alcoholic patients. Transpl Int 2005;18:491–8., .
Liver transplantation for alcoholic cirrhosis: long term follow-up and impact of disease recurrence. Transplantation 2001;72:619–26., , , et al.
Long-term follow-up of patients diagnosed with alcohol dependence or alcohol abuse who were evaluated for liver transplantation. Liver Transpl 2001;7:581–7., , , et al.
Orthotopic liver transplantation for alcoholic liver disease: rates of survival, complications and relapse. Hepatogastroenterology 1997;44:1356–9., , , et al.
Liver transplantation for alcoholic liver disease. Clin Transplant 1996;10(6 Pt 2):676–9., , , et al.
Liver transplantation for alcoholic liver disease. Br J Psychiatry 1997;171:497–500., .
Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg 1997;3:628–37., , , et al.
Predicting recidivism after orthotopic liver transplantation for alcoholic liver disease. Hepatology 1994;20(1 Pt 1):105–10., , , et al.
Alcoholic cirrhosis is a good indication for liver transplantation, even for cases of recidivism. Gut 1999;45:421–6., , , et al.
Liver transplantation for alcoholic liver disease with or without hepatitis C. Int J Surg Pathol 2002;10:115–22., , , et al.
Long-term follow-up after liver transplantation for alcoholic liver disease under tacroimus. Transplantation 2000;70:1335–42., , , et al.
Alcohol relapse and functional outcome after liver transplantation for alcoholic liver disease. Liver Transpl 2001;7:204–5., .
Liver transplantation in patients with chronic hepatitis C and alcoholism. Dig Dis Sci 1999;44:2003–7., , et al.
Patterns of alcohol consumption after liver transplantation. Gut 1998;43:140–5., , , et al.
Alcoholic recidivism after liver transplantation for alcoholic cirrhosis. J Clin Gastroenterol 1998;26:204–6., , , et al.
Orthotopic liver transplantation for alcoholic liver disease. Hepatology 1990;11:159–64., , , et al.
Liver transplantation in patients with alcoholic cirrhosis: selection criteria and rates of survival and relapse. BMJ 1990;301:15–17., , , et al.
Liver transplantation for alcoholic liver disease. Surgery 1992;112:694–701., , , et al.
Liver transplantation for alcoholic cirrhosis. Transpl Int 2000:13(Suppl 1):S127–30., , , et al.
Alcohol use following liver transplantation for alcoholic cirrhosis. Transplantation 1996;62:1060–3., , , et al.
Efficacy of liver transplantation for alcoholic cirrhosis with respect to recidivism and compliance. Transplantation 1994;58:560–5., , , et al.